BioSpace News Archive

Novel Small Molecule and Antibody Conjugate Approaches Expected to Enable Broad Adoption of Boron Neutron Capture Therapy

Echo® MS System delivers ultra-high throughput screening to redefine high-throughput quantification of molecules

Prosthetics manufacturer Steeper Group, who trade as SteeperUSA from San Antonio, Texas, has completed acquisition of the Espire Elbow range from Michigan based College Park Industries.

LabMinds, Inc., an award-winning robotics company in life sciences, today announced it has closed a fully subscribed funding round from a mix of private and strategic investors.

Qosina offers a wide selection of in-stock tubing for prototyping and large-scale production requirements.

PTU Elite: Soft Skills Program Sharpens Techs’ Skills to Foster Harmonious, Well-Rounded Pharmacy Teams

Quality control measures for drug development are of utmost importance as inadvertent presence of unknown pharmaceutical ingredients can further complicate health conditions of the patients.

A new report by Persistence Market Research presents interesting facets of the global cloud-based drug discovery platform market and provides value forecasts for an eight year period from 2017 to 2025.

According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS), (“Marinus” or the “Company”) today announced the closing of an underwritten public offering of 18,400,000 shares of common stock at a public offering price of $2.50 per share, including the exercise in full by the underwriters of their option to purchase up to 2,400,000 additional shares of common stock.